Skip to main content
. 2019 Jun 13;6:2054358119854113. doi: 10.1177/2054358119854113

Figure 3.

Figure 3.

Use of antihyperglycemic classes by CKD stage and prior CVD.

Note. CKD = chronic kidney disease; CVD = cardiovascular disease; DPP-4 = dipeptidyl peptidase-4; SGLT2 = sodium glucose co-transporter 2; GLP-1 = glucagon-like peptide 1; CAD = coronary artery disease; PAD = peripheral artery disease; TIA = transient ischemic attack.